VESIcare LS Alternatives Compared
| VESIcare LS | Solifenacin | Botox |
|
|---|
| VESIcare LS (solifenacin) | Solifenacin | Botox (onabotulinumtoxinA) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neurogenic Bladder, Neurogenic Detrusor Overactivity. VESIcare LS may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Overactive Bladder, Urinary Incontinence, Neurogenic Bladder, Urinary Frequency, Neurogenic Detrusor Overactivity. solifenacin may also be used for purposes not listed in this medication guide. View more |
Prescription only
Botox is approved to treat many conditions, such as chronic migraine, involuntary muscle contractions or twitching, excessive sweating, increased saliva, and overactive bladder to name a few. Botox... View more |
Related suggestions Neurogenic Detrusor Overactivity
Neurogenic Bladder
|
|||||||||||||||||||||||
| More about VESIcare LS (solifenacin) | More about Solifenacin | More about Botox (onabotulinumtoxinA) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Solifenacin has an average rating of 5.4 out of 10 from a total of 199 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 37% reported a negative effect. |
Botox has an average rating of 5.7 out of 10 from a total of 468 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 42% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: VESIcare LS side effects in more detail. |
See also: solifenacin side effects in more detail. |
See also: Botox side effects in more detail. |
||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all VESIcare LS prices |
View all solifenacin prices |
View all Botox prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other solifenacin brands include: VESIcare | VESIcare, VESIcare LS | Other onabotulinumtoxinA brands include: Botox Cosmetic | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
68 hours |
68 hours |
N/A |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 486 drugs are known to interact with VESIcare LS:
|
A total of 486 drugs are known to interact with solifenacin:
|
A total of 119 drugs are known to interact with Botox:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 26, 2020 |
November 19, 2004 |
December 09, 1991 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.